Triglycerides rise for many reasons, yet insulin determines how the body routes and stores calories. In a normal metabolic state, insulin guides nutrients into muscle, liver, and subcutaneous fat with steady control. In insulin resistance, this coordination weakens and shifts calories toward visceral fat, higher VLDL output, and rising triglycerides. These internal shifts influence body shape, blood pressure, cholesterol particles, and diabetes risk. The Waist-to-Height Ratio offers a clear window into these deeper metabolic patterns.
1. How Triglycerides Form Under Normal Insulin Function
Insulin organizes nutrient flow after meals in a controlled sequence. Extra glucose moves through glycolysis and becomes acetyl-CoA. When glycogen stores reach comfortable capacity, part of this acetyl-CoA enters de novo lipogenesis (new fat creation) to form fatty acids. The liver then creates triglycerides and packages them into VLDL particles. Insulin activates lipoprotein lipase in fat tissue to support efficient storage, while signaling muscles to utilize glucose for fuel, thus keeping serum VLDL levels low.
Extra Calories and Body Shape in a Normal State
Caloric surplus spreads across multiple tissues because insulin opens broad storage pathways. Muscle stores glycogen first and the liver follows. Subcutaneous fat (the “good” fat) absorbs the remaining surplus and grows gradually. Visceral fat (the “bad” fat) expands slowly in this state, which maintains a stable body shape and reduces pressure on the liver.
Quick Points
- Subcutaneous fat stores most excess calories.
- Waistline expands proportionately with total weight.
- ApoB and small LDL remain low.
- Blood pressure stays stable.
- Waist-to-Height ratio remains healthy (typically < 0.5).
2. How Insulin Resistance Alters Triglyceride Synthesis
In insulin resistance, muscle cells take up less glucose and store less glycogen (leading to muscle loss). More glucose reaches the liver, which fills glycogen early and then shifts toward more aggressive triglyceride synthesis. Reactive high insulin levels activate lipogenesis (fat creation), while fat cells release extra fatty acids because insulin no longer suppresses lipolysis (fat breakdown and release) effectively. The liver merges these fatty acids with glucose-derived acetyl-CoA, which accelerates VLDL formation. Over time, this raises ApoB, non-HDL cholesterol, and small LDL particle number.
Extra Calories and Body Shape in Insulin Resistance
Caloric distribution shifts toward visceral fat because muscle and subcutaneous fat lose efficiency. Visceral fat expands earlier and faster. The abdomen becomes the primary storage site; even if weight increases elsewhere, the waist expands disproportionately fast, while muscle quality in the limbs decreases. This pattern reflects deeper hormonal resistance and signals that the liver receives more fuel than it can handle, which over time can lead to fatty liver disease (clinically known as MASH, or metabolic dysfunction-associated steatohepatitis).
Quick Points
- Visceral fat expansion accelerates with insulin resistance.
- Waistline increases faster than overall weight.
- Waist-to-Height ratio increases (worsens) early.
- ApoB and non-HDL cholesterol rise as VLDL increases.
- Small LDL particles increase because triglyceride-rich lipoproteins remodel into denser particles.
- Blood pressure trends higher with vascular insulin resistance.
- Diabetes risk rises due to chronic beta cell strain.
3. How Caloric Surplus Intensifies Triglyceride Formation
Caloric surplus pressures metabolism in both states, yet insulin resistance magnifies the effect. Excess carbohydrates deliver more glucose to the liver, excess fat raises fatty acid supply, and excess protein adds gluconeogenic substrates. When insulin resistance exists, the liver cannot distribute this load effectively and converts more components into triglycerides. Visceral fat then releases even more fatty acids in a vicious cycle, which further increases VLDL production and destabilizes lipid patterns.
Quick Points
- The liver becomes the main site of overload.
- Triglycerides rise rapidly.
- ApoB increases with higher VLDL turnover.
- Small LDL particle number rises as lipoproteins remodel.
- Blood pressure and glucose drift upward.

4. The Waist-to-Height Ratio as a Metabolic Signal
This ratio reflects how the body partitions calories relative to your frame. In normal insulin states, fat accumulates mostly in subcutaneous depots, and the ratio stays stable. In insulin resistance, visceral fat expands earlier and faster, and the ratio rises long before fasting glucose changes. A general clinical goal is to keep your waist circumference to less than half your height.
A Monozygotic Twin Example
Imagine identical twins with equal baseline weight and identical high-calorie intake.
- Twin A, with normal insulin sensitivity, distributes calories evenly across muscle glycogen, liver glycogen, and subcutaneous fat. Her waistline rises slowly, her Waist-to-Height ratio stays near 0.5, and ApoB remains low. Blood pressure and glucose remain normal.
- Twin B, with insulin resistance, stores fewer calories in muscle and more in the liver and visceral fat. Her waistline expands faster than her hips or limbs, her Waist-to-Height ratio climbs above 0.5, and triglycerides rise. ApoB increases, small LDL particles grow, and diabetes risk increases even though calories are identical.
Patient Cases
- Case 1 — Early Central Expansion with Rising Particles: A 42-year-old man notices a thicker waist and an increasing Waist-to-Height ratio. His triglycerides rise from 115 to 190 and ApoB increases. Structured meals and movement lower his abdominal fat and improve his lipid profile.
- Case 2 — Even Fat Gain with Stable Metabolism: A 33-year-old woman gains weight evenly across her body during a stressful season. Her waistline changes proportionately. Triglycerides remain stable at 105 and ApoB stays normal. Balanced habits restore her baseline.
- Case 3 — Lean Body with High ApoB: A 55-year-old man carries abdominal fat despite normal overall weight. His triglycerides reach 240 and ApoB increases. Imaging identifies visceral fat. Targeted intervention improves his waistline and lipid markers.
- Case 4 — Evening Surplus and Central Fat Growth: A 37-year-old woman eats late most days. Her waistline expands faster than her weight and her triglycerides rise. Adjusting timing improves her insulin response and reduces central fat.
- Case 5 — Lipodystrophy-Like Pattern with High VLDL: A 48-year-old woman stores fat mostly in her abdomen while her limbs remain lean. Triglycerides stay near 260 and ApoB rises. Structured activity reduces visceral fat and lowers VLDL output.
Summary Table
| Feature | Normal Insulin State | Insulin-Resistant State |
|---|---|---|
| Muscle glycogen storage | High | Low |
| Liver triglyceride output | Low | High |
| Fat distribution | Subcutaneous (the “good” fat) | Visceral (the “bad” fat) |
| Body morphology | Evenly round | Central or lipodystrophy-like |
| Waist-to-Height Ratio | Stable (Keep < 0.5) | Increased (> 0.5) |
| Triglycerides | Stable | Elevated |
| ApoB | Controlled | High |
| Non-HDL cholesterol | Normal | Increased |
| Small LDL particles | Low | High |
| Blood pressure | Stable | Higher |
| Diabetes risk | Low | Increased |
Closing Thoughts
At our practice in Montgomery County, Maryland, and through virtual care, we use a comprehensive and thoughtful strategy that supports metabolic health from multiple perspectives. This approach improves long-term outcomes without adding new risks.
- Insulin Regulation of Hepatic Lipid Homeostasis. Uehara K, Santoleri D, Whitlock AEG, Titchenell PM. Comprehensive Physiology. 2023;13(3):4785-4809. doi:10.1002/cphy.c220015.
- Unraveling the Regulation of Hepatic Metabolism by Insulin. Titchenell PM, Lazar MA, Birnbaum MJ. Trends in Endocrinology and Metabolism: TEM. 2017;28(7):497-505. doi:10.1016/j.tem.2017.03.003.
- Contributions of De Novo Synthesis of Fatty Acids to Total VLDL-triglyceride Secretion During Prolonged Hyperglycemia/Hyperinsulinemia in Normal Man. Aarsland A, Chinkes D, Wolfe RR. The Journal of Clinical Investigation. 1996;98(9):2008-17. doi:10.1172/JCI119005.
- Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease. Shulman GI. The New England Journal of Medicine. 2014;371(12):1131-41. doi:10.1056/NEJMra1011035.
- Lipid and Lipoprotein Dysregulation in Insulin Resistant States. Avramoglu RK, Basciano H, Adeli K. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2006;368(1-2):1-19. doi:10.1016/j.cca.2005.12.026.
- Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia. Sparks JD, Sparks CE, Adeli K. Arteriosclerosis, Thrombosis, and Vascular Biology. 2012;32(9):2104-12. doi:10.1161/ATVBAHA.111.241463.
- Mechanisms of Metabolic Dyslipidemia in Insulin Resistant States: Deregulation of Hepatic and Intestinal Lipoprotein Secretion. Avramoglu RK, Qiu W, Adeli K. Frontiers in Bioscience : A Journal and Virtual Library. 2003;8:d464-76. doi:10.2741/1022.
- A Simple Cut-Off for Waist-to-Height Ratio (0·5) Can Act as an Indicator for Cardiometabolic Risk: Recent Data From Adults in the Health Survey for England. Gibson S, Ashwell M. The British Journal of Nutrition. 2020;123(6):681-690. doi:10.1017/S0007114519003301.
- A Proposal for a Primary Screening Tool: ‘Keep Your Waist Circumference to Less Than Half Your Height’. Ashwell M, Gibson S. BMC Medicine. 2014;12:207. doi:10.1186/s12916-014-0207-1.
- A Systematic Review of Waist-to-Height Ratio as a Screening Tool for the Prediction of Cardiovascular Disease and Diabetes: 0·5 Could Be a Suitable Global Boundary Value. Browning LM, Hsieh SD, Ashwell M. Nutrition Research Reviews. 2010;23(2):247-69. doi:10.1017/S0954422410000144.
About Dr. Gerti Tashko, MD
Dr. Gerti Tashko, MD, is an endocrinologist in Montgomery County, Maryland. He is uniquely quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice delivers root-cause-focused metabolic and endocrine care, available virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to improve long-term health.




